Literature DB >> 11890682

Phosphatase and oxygen radical-generating activities of mammalian purple acid phosphatase are functionally independent.

Helena Kaija1, Sari L Alatalo, Jussi M Halleen, Ylva Lindqvist, Gunter Schneider, H Kalervo Väänänen, Pirkko Vihko.   

Abstract

Bone-resorbing osteoclasts and activated macrophages express large amounts of tartrate-resistant acid phosphatase (TRAP), an iron-containing enzyme with unknown biological function. We studied acid phosphatase (AcP) and reactive oxygen species (ROS)-generating activities of recombinant rat TRAP. pH optimum was 4.5 for AcP activity and 6.5 for ROS-generating activity. Replacement of His113 and His216 by site-directed mutagenesis severely inhibited AcP activity, but had no significant effects on ROS-generating activity. Substrate specificity was not affected by the mutations. These results suggest that AcP and ROS-generating activities of TRAP are functionally independent. (C)2002 Elsevier Science (USA).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11890682     DOI: 10.1006/bbrc.2002.6615

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  Genetic deficiency of tartrate-resistant acid phosphatase associated with skeletal dysplasia, cerebral calcifications and autoimmunity.

Authors:  Ekkehart Lausch; Andreas Janecke; Matthias Bros; Stefanie Trojandt; Yasemin Alanay; Corinne De Laet; Christian A Hübner; Peter Meinecke; Gen Nishimura; Mari Matsuo; Yoshiko Hirano; Sylvie Tenoutasse; Andrea Kiss; Rafael Fabiano Machado Rosa; Sharon L Unger; Raffaele Renella; Luisa Bonafé; Jürgen Spranger; Sheila Unger; Bernhard Zabel; Andrea Superti-Furga
Journal:  Nat Genet       Date:  2011-01-09       Impact factor: 38.330

2.  Phosphate forms an unusual tripodal complex with the Fe-Mn center of sweet potato purple acid phosphatase.

Authors:  Gerhard Schenk; Lawrence R Gahan; Lyle E Carrington; Natasa Mitic; Mohsen Valizadeh; Susan E Hamilton; John de Jersey; Luke W Guddat
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-29       Impact factor: 11.205

3.  Guanidine- and purine-functionalized ligands of FeIIIZnII complexes: effects on the hydrolysis of DNA.

Authors:  Claudia Pereira; Giliandro Farias; Filipy G Maranha; Nathalia Castilho; Gerhard Schenk; Bernardo de Souza; Hernán Terenzi; Ademir Neves; Rosely A Peralta
Journal:  J Biol Inorg Chem       Date:  2019-07-02       Impact factor: 3.358

4.  Structural and kinetic properties of a novel purple acid phosphatase from phosphate-starved tomato (Lycopersicon esculentum) cell cultures.

Authors:  Gale G Bozzo; Kashchandra G Raghothama; William C Plaxton
Journal:  Biochem J       Date:  2004-01-15       Impact factor: 3.857

5.  Biomarkers for identifying the early phases of osteoarthritis secondary to medial patellar luxation in dogs.

Authors:  Md Rafiqul Alam; Joong Ryong Ji; Min Su Kim; Nam Soo Kim
Journal:  J Vet Sci       Date:  2011-09       Impact factor: 1.672

6.  Optimal level of purple acid phosphatase5 is required for maintaining complete resistance to Pseudomonas syringae.

Authors:  Sridhar Ravichandran; Sophia L Stone; Bernhard Benkel; Junzeng Zhang; Fabrice Berrue; Balakrishnan Prithiviraj
Journal:  Front Plant Sci       Date:  2015-08-04       Impact factor: 5.753

7.  Purple Acid Phosphatase5 is required for maintaining basal resistance against Pseudomonas syringae in Arabidopsis.

Authors:  Sridhar Ravichandran; Sophia L Stone; Bernhard Benkel; Balakrishnan Prithiviraj
Journal:  BMC Plant Biol       Date:  2013-07-29       Impact factor: 4.215

8.  A Potent Tartrate Resistant Acid Phosphatase Inhibitor to Study the Function of TRAP in Alveolar Macrophages.

Authors:  Carian E Boorsma; T Anienke van der Veen; Kurnia S S Putri; Andreia de Almeida; Christina Draijer; Thais Mauad; Gyorgy Fejer; Corry-Anke Brandsma; Maarten van den Berge; Yohan Bossé; Don Sin; Ke Hao; Anja Reithmeier; Göran Andersson; Peter Olinga; Wim Timens; Angela Casini; Barbro N Melgert
Journal:  Sci Rep       Date:  2017-10-03       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.